Pra Health Sciences Inc 's ROA from the first quarter of 2021 to the first quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Pra Health Sciences Inc 's ROA in the first quarter of 2021?
Pra Health Sciences Inc achieved a return on average assets (ROA) of 5.57 % in its first quarter of 2021, this is above PRAH's average return on assets of 4.38%.
Pra Health Sciences Inc s assets during the 12 months ending in the first quarter of 2021 are valued at $3 billion

ROA has improved compared to 5.36% in the fourth quarter of 2020, due to net income growth.

However, within the Healthcare sector 153 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2021 quarter, so far to 1178, from total ROA ranking in the fourth quarter of 2020 at 1199.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Mar 31 2021) I. Quarter	(Dec 31 2020) IV. Quarter	(Sep 30 2020) III. Quarter	(Jun 30 2020) II. Quarter	(Mar 31 2020) I. Quarter
Y / Y Total Assets Change	17.57 %	19.03 %	4.63 %	2.91 %	1.85 %
Y / Y Net Income Change	40.04 %	-31.48 %	9.93 %	-66.21 %	-8.13 %
Net Income (TTM) in million	213	197	221	212	240
Return On Assets (TTM)	5.57 %	5.36 %	6.28 %	6.11 %	6.95 %
PRAH's Total Ranking	# 1178	# 1199	# 853	# 852	# 829
Total Assets (TTM) in million	4,114	3,989	3,663	3,543	3,499
Seq. Total Assets Change	3.14 %	8.91 %	3.39 %	1.25 %	4.42 %
Seq. Net Income Change	11.09 %	-43.83 %	557.72 %	-65.88 %	-45.64 %

PRAH's 5 Years Annual ROA >> Back to PRAH Management Effectiveness >> Compare PRAH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 11
Sector	# 154
Overall	# 1152

Return On Assets Statistics
High	Average	Low
7.06 %	4.38 %	1.37 %
(Sep 30 2019)

Financial Statements
Pra Health Sciences Inc 's Assets	$ 4,114 million	PRAH's Balance sheet
Pra Health Sciences Inc 's Income	$ 57 million	Quarterly PRAH's Income Statement
PRAH's Income by Division		See PRAH's Income by Division

Annual Return On Assets	(Dec 31 2020) FY 2020	(Dec 31 2019) FY 2019	(Dec 31 2018) FY 2018	(Dec 31 2017) FY 2017	(Dec 31 2016) FY 2016
Y / Y Total Assets Change	19.03 %	5.16 %	-5.11 %	53.31 %	-1.72 %
Total Assets in million	3,989	3,351	3,186	3,358	2,190
Y / Y Net Income Change	-18.95 %	57.4 %	76.2 %	28.58 %	-16.62 %
Net Income in million	197	243	154	88	68
Annual Return On Assets	4.94 %	7.26 %	4.85 %	2.61 %	3.11 %

PRAH's 5 Years Annual ROA >> Back to PRAH Management Effectiveness >> Compare PRAH ROA to its Competitors

Comment on PRAH's ROA in the fiscal year ending 2020

In the fiscal year 2020 Pra Health Sciences Inc 's ROA decreased compared to previous year to 4.94 %, due to deterioration of net income -18.95 % to $197.04 million, from $243.12 million a year ago, as PRAH's assets were $3,988.70 million.

More Return On Assets Ratios
PRAH's' Return on Assets at Yahoo Finance
Medical Laboratories Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRAH's Roa Ratio versus Medical Laboratories Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRAH's Competitors
Subscribers only: Roa for Pra Health Sciences Inc 's Suppliers
Subscribers only: Return On Assets for PRAH's Customers

You may also want to know
PRAH's Roi	PRAH's Inventory Turnover Ratio	PRAH's Growth Rates	PRAH's Dividend Comparisons
	PRAH's Profitability Ratios	PRAH's Asset Turnover Ratio	PRAH's Dividend Growth
PRAH's Roe	PRAH's Valuation Ratios	PRAH's Financial Strength Ratios	PRAH's Dividend Payout Ratio

Companies with similar Return On Assets at Mar 31 2021, within Healthcare Sector	ROA
Voyager Therapeutics Inc	14.76 %
Revvity Inc	14.21 %
Emergent Biosolutions Inc	14.17 %
Incyte Corporation	13.93 %
Masimo Corp	13.77 %
Biomarin Pharmaceutical Inc	13.76 %
Labcorp Holdings Inc	13.72 %
Quest Diagnostics Inc	13.67 %
Eli Lilly And Company	13.59 %
Healthcare Services Group Inc	13.49 %
Dexcom Inc	13.23 %
Zoetis Inc	13.07 %
Amedisys Inc	12.74 %
Pacira Biosciences inc	12.71 %
Biogen Inc	12.42 %
3m Company	12.41 %
Edwards Lifesciences Corporation	12.30 %
Medpace Holdings Inc	11.92 %
Magellan Health inc	11.76 %
Royalty Pharma Plc	11.71 %
Atrion Corporation	11.69 %
Surface Oncology Inc	11.60 %
Biodelivery Sciences International Inc	11.17 %
Encision Inc	11.13 %
Amgen Inc	11.11 %
Intuitive Surgical Inc	10.92 %
Hca Healthcare Inc	10.84 %
Xoma Royalty Corporation	10.20 %
Nature s Sunshine Products inc	10.05 %
Align Technology inc	9.99 %

Date modified: 2026-09-12T06:15:30+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.